Addiction Biomarkers: Dimensional Approaches to Understanding Addiction

scientific article

Addiction Biomarkers: Dimensional Approaches to Understanding Addiction is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1016/J.MOLMED.2017.12.007
P932PMC publication ID6233300
P698PubMed publication ID29307501

P2093author name stringDavid Goldman
Warren K Bickel
Laura E Kwako
P2860cites workNeurocircuitry of addictionQ24647156
The endophenotype concept in psychiatry: etymology and strategic intentionsQ28187744
Endophenotype, intermediate phenotype, biomarker: definitions, concept comparisons, clarificationsQ28283567
Research domain criteria (RDoC): toward a new classification framework for research on mental disordersQ29547877
Adrenocortical and pituitary glucocorticoid feedback in abstinent alcohol-dependent womenQ30412895
The addicted human brain: insights from imaging studiesQ30794301
The behavioral economics and neuroeconomics of reinforcer pathologies: implications for etiology and treatment of addictionQ33667413
The future is now: reducing impulsivity and energy intake using episodic future thinkingQ33726443
The anxious amygdala: CREB signaling and predisposition to anxiety and alcoholismQ34048514
The future is now: comparing the effect of episodic future thinking on impulsivity in lean and obese individualsQ34288959
A psychobiological model of temperament and characterQ34345595
The genetics of addictions: uncovering the genesQ34431107
Affiliation with Alcoholics Anonymous after treatment: a study of its therapeutic effects and mechanisms of actionQ34443127
Neurobiology of addiction: a neurocircuitry analysisQ34535855
Management of drug and alcohol withdrawalQ35118593
Use of biomarkers for alcohol use disorders in clinical practiceQ35675693
The behavioral economics of substance use disorders: reinforcement pathologies and their repairQ35848851
Unstuck in time: episodic future thinking reduces delay discounting and cigarette smokingQ36110859
Which alcohol use disorder criteria contribute to the association of ADH1B with alcohol dependence?Q36113070
Clinical and Biological Risk Factors for Neuropsychological Impairment in Alcohol Use DisorderQ36129828
The neurobiology of addiction: a neuroadaptational view relevant for diagnosisQ36575834
Dissection of hypothalamic-pituitary-adrenal axis pathology in 1-month-abstinent alcohol-dependent men, part 1: adrenocortical and pituitary glucocorticoid responsivenessQ36977625
Determinants of alcohol use and abuse: Impact of quantity and frequency patterns on liver diseaseQ37018732
Reduced hedonic capacity in major depressive disorder: evidence from a probabilistic reward taskQ37088803
The behavioral- and neuro-economic process of temporal discounting: A candidate behavioral marker of addictionQ37381671
Addictions Neuroclinical Assessment: A Neuroscience-Based Framework for Addictive DisordersQ38698027
Episodic Future Thinking: Expansion of the Temporal Window in Individuals with Alcohol DependenceQ38860055
Prospective memory and future event simulation in individuals with alcohol dependenceQ39618635
Episodic future thinking reduces reward delay discounting through an enhancement of prefrontal-mediotemporal interactionsQ39882040
Increases in Drug and Opioid-Involved Overdose Deaths - United States, 2010-2015.Q40403142
The impact of alcohol dependence and posttraumatic stress disorder on cold pressor task response.Q43453839
Alcohol involvement in opioid pain reliever and benzodiazepine drug abuse-related emergency department visits and drug-related deaths - United States, 2010.Q43980031
Mild opioid deprivation increases the degree that opioid-dependent outpatients discount delayed heroin and moneyQ44119373
The global epidemiology and burden of opioid dependence: results from the global burden of disease 2010 studyQ44344114
Impaired serum cortisol stress response is a predictor of early relapse.Q44360222
Reinforcer Pathology: The Behavioral Economics of Abuse Liability TestingQ45040019
Bleak Present, Bright Future: Online Episodic Future Thinking, Scarcity, Delay Discounting, and Food Demand.Q45068940
Decreases in dopamine receptors but not in dopamine transporters in alcoholicsQ48846413
Toward Narrative Theory: Interventions for Reinforcer Pathology in Health BehaviorQ57827471
Heterogeneity of alcohol use disorder: understanding mechanisms to advance personalized treatmentQ87037732
P921main subjectbiomarkerQ864574
P577publication date2018-01-04
P1433published inTrends in Molecular MedicineQ15265842
P1476titleAddiction Biomarkers: Dimensional Approaches to Understanding Addiction

Reverse relations

cites work (P2860)
Q90782255Cognitive impairment in substance use disorders
Q64230853Compulsivity in Alcohol Use Disorder and Obsessive Compulsive Disorder: Implications for Neuromodulation
Q90597805Developing neuroscience-based treatments for alcohol addiction: A matter of choice?
Q99711311Evidence That Cannabis Exposure, Abuse, and Dependence Are Related to Glutamate Metabolism and Glial Function in the Anterior Cingulate Cortex: A 1H-Magnetic Resonance Spectroscopy Study
Q60939246Interaction Between Stress and Addiction: Contributions From Latin-American Neuroscience
Q57162399Neuroimaging, neuromodulation, and population health: the neuroscience of chronic disease prevention
Q55717539Non-medical Cannabis Self-Exposure as a Dimensional Predictor of Opioid Dependence Diagnosis: A Propensity Score Matched Analysis.
Q57169837Not all drugs are created equal: impaired future thinking in opiate, but not alcohol, users

Search more.